USPTO serial 79166346
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Protective preparations for vaginal mucous not for medical purposes, namely, non-medicated douches; protective preparations for oral mucous not for medical purposes, namely, non-medicated mouth rinse; slow-release anhydrous patches containing non-medicated skin lotions for damaged skin not for medical purposes; protective preparations for genital mucous not for medical purposes, namely, non-medicated douches; non-medicated toiletries; products for oral hygiene, namely, mouthwash; hair gels, shaving gels; vaginal gels not for medical purposes, namely, vaginal moisturizers, hydrating gels and feminine hygiene wash; skin care products, namely, non-medicated skin creams and gels; hair care preparations and non-medicated hair care treatments for cosmetic purposes; hair removal preparations being shaving preparations; animal grooming preparations, namely, pet shampoo and horse shampoo; cosmetics, hair lotions | SECTION 71 - CANCELLED | — |
| 005 | protective preparations for vaginal mucous for medical purposes, namely, medicated douches, gels and vaginal washes; protective preparations for oral mucous for medical purposes, namely, medicated mouth rinse and mouth wash; slow-release transdermal anhydrous patches for use in the treatment of damaged skin for medical purposes; protective preparations for genital mucous for medical purposes, namely, medicated douches and gels; periocular decongestant cryogen gel for medical purposes; protective plasters for medical purposes; sterile periocular cleansing gauze; transdermal patches for use in the treatment of herpes; transdermal patches for use in the treatment of verrucae; sterile gauze for damaged skin; sterile gauze for compression and absorption of exudates; nasal plasters being medical plasters; transdermal cryogenic patches for use in the treatment of fever; protective preparations for joint and muscular pain in the form of cream; protective preparations for joint and muscular pain in the form of gel; dermal patches for transdermal administration of pharmaceutical preparations, namely, for rheumatologic, gynaecological, urological, oncologic, rhinological, ophthalmologic and dermatological use; medical plasters for scars; nutraceuticals for use as dietary supplements; nutritional supplements for animals; dental articles and preparations, namely, dental abrasives, dental cements, dental impression materials, dental lacquer, dental mastics; Pads as adhesives for dentures; disinfectants for sanitary and medical purposes and antiseptics; absorbent articles for personal hygiene, namely, adult diapers; feminine hygiene pads; nappies for babies and incontinents; live organs and tissues for surgical purposes; preparations for diagnostics for medical purposes; pharmaceutical preparations for oral and dental care; pharmaceutical preparations for rheumatologic, gynaecological, urological, oncologic, rhinological, ophthalmologic and dermatological use; pharmaceutical preparations for the treatment of parodontopathics, aphtosis and for facilitating regeneration of oral tissue; pharmaceutical preparations for the treatment of joints; pharmaceutical preparations for use in diagnostics; pharmaceutical preparations for use in tissue engineering, cosmetic and orthopedic surgery; veterinary preparations for the treatment of joint diseases in horses; sanitary preparations for medical purposes; dietary supplements for humans and animals; medical plasters, medical and surgical dressings; dental wax; disinfectants for the skin | SECTION 71 - CANCELLED | — |
| 010 | contraceptive apparatus; wound drainage apparatus, suture needles, surgical staples; medical syringes and cannulas; applicators and medical devices, namely, medical and surgical syringes and injectors for the administration of pharmaceutical preparations; medical and surgical devices for dermatological use and for use during cosmetic and plastic surgery; suture materials | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 12, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Feb 13, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jan 22, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jan 22, 2024 | INPC | INVALIDATION PROCESSED | — |
| Jan 12, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 12, 2023 | C71T | CANCELLED SECTION 71 | — |
| Jun 11, 2020 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| May 23, 2017 | CORV | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | — |
| Mar 10, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 16, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 16, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 1, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 31, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 11, 2016 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 1, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 16, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 27, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 27, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 27, 2016 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 11, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 2, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 1, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 1, 2016 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 11, 2016 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 8, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 18, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 17, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 17, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 4, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 18, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 18, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 16, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 15, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 8, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 8, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 4, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |